Martin Dow Group is an innovation-driven group committed to providing a broad range of high-quality medicines and formulations that deliver on the promise of better patient outcomes.
Our capabilities span a wide range of therapeutic areas, and our EU GMP compliant manufacturing facilities are outfitted with robust technologies dedicated to providing consistent quality and developing high-performing Pharmaceutical and Nutraceutical products that excel in terms of efficacy and cost-effectiveness.
All of our international manufacturing facilities are certified by ANSM, Synadiet, Ecocert, DG CCRF, and Agriculture Biologique, and adhere to the strictest international standards in order to provide results that satisfy our partners’ and consumers’ unmet needs.
Creating distinction for life has always been at the core of our business practices at Martin Dow. To attain this distinction, we have a quality-driven approach from manufacturing to delivering high-value products to our consumers and partners.
We have a dedicated new product development (NPD) Lab, a state-of-the-art facility recognized by the local drug regulatory body. It is equipped with the latest equipment for manufacturing, packaging, and testing new products.
At Martin Dow, we invest in cGMP compliant manufacturing technologies and state-of-the-art facilities built to international standards.